Evidence map›Paper›PMID 40691752›Full record

ArticleAnalytical sciences : the international journal of the Japan Society for Analytical Chemistry2025

A dual-antibody sandwich immunoassay using upconversion nanoparticles and magnetic beads for fibrinogen detection.

Ke Lv, Weitao Wang, Li Zhang, Xi Zhou, Hongyan Yu, Xiaole Han, Li Wang, Guoming Xie, Gang Yang

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Magnetic nanomaterials in analytical chemistry: toward enhanced separation and detection methodologies.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ke Lv *Department of Neurosurgery, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Chongqing, 40016, People's Republic of China.
Weitao Wang *Department of Neurosurgery, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Chongqing, 40016, People's Republic of China.
Li ZhangKey Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, People's Republic of China.
Xi ZhouDepartment of Laboratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400000, People's Republic of China.
Hongyan YuKey Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, People's Republic of China.
Xiaole HanKey Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, People's Republic of China.
Li WangThe Center for Clinical Molecular Medical Detection, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China.
Guoming XieKey Laboratory of Clinical Laboratory Diagnostics (Chinese Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, People's Republic of China.
Gang YangDepartment of Neurosurgery, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Chongqing, 40016, People's Republic of China. gangyang@hospital.cqmu.edu.cn.

Funding

Chongqing Postdoctoral Science Foundation CSTB2022NSCQ-BHX0671National Natural Science Foundation of China 82201633
6 · The paper itself

Abstract

Fibrinogen is a vital biomarker for coagulation disorders, with reduced levels increasing bleeding risk and mortality, requiring rapid detection for early diagnosis. Enzyme-linked immunosorbent assay (ELISA) is commonly employed in clinical environments; however, its prolonged processing duration and insufficient sensitivity hinder its utility for swift diagnostics. We addressed these limitations by creating a dual-antibody sandwich immunoassay that employs upconversion nanoparticles (UCNPs) and magnetic beads (MBs) for the precise and sensitive detection of fibrinogen. The enhanced analytical performance of the method is attributed to the use of UCNPs and MBs. UCNPs enhance the signal-to-noise ratio by emitting visible light under near-infrared excitation, which reduces background interference from autofluorescence and light scattering in biological samples. Meanwhile, MBs facilitate specific enrichment of fibrinogen by selectively capturing the target analyte, enabling efficient isolation from complex sample matrices. This synergy improves sensitivity and specificity, achieving a 2 ng/mL detection limit with a 15-fold sensitivity increase, simpler operation, and shorter detection time compared to conventional ELISA kits. This platform offers a robust solution for fibrinogen detection, with potential for broad application in clinical diagnostics.

Indexed as

AntibodiesFibrinogenNanoparticlesHumansImmunoassayLimit of DetectionAntibodiesFibrinogenDual-antibody sandwich immunoassayFibrinogen detectionMagnetic beads (MBs)Upconversion nanoparticles (UCNPs)

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.